Landscapes / Companies
Getz Pharma not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
1 in Phase 3
Drugs
3
in active trials · 4 in all
Trials
3 active
8 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved in other | 31 Dec 2026Phase 4 trial completes | |||
| Next date | 31 Dec 2026 · Phase 4 trial completes | ||||
| Also tested for | Type II Diabetes Mellitus, Efficacy, Self and 1 more | ||||
| Open drug page | |||||
Ertugliflozinnot checked |
Sodium-glucose co-transporter inhibitor |
On the market | — | ||
| How it works | Makes the kidneys flush extra sugar and salt into the urine | ||||
| Also tested for | Liver Fat, Liver Fibrosis and 4 more | ||||
| Open drug page | |||||
— |
Phase 3 | 30 Dec 2026Phase 3 trial completes | |||
| Next date | 30 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Postprandial Distress Syndrome | ||||
| Open drug page | |||||
About
- No active trial
- Vildagliptin
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021